Stock Information
Janux Therapeutics Inc (JANX)
Ticker Symbol: JANX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $850.93 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.675
Revenue (TTM): $0.16 M
Dividend Yield: N/A%
ROE: -10.18%
Latest News
-
Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion
Fri, Jan 23, 2026 3:52 PM
Key Financials
Financial data not available